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ABSTRACT: Mitochondrial dysfunction impairs muscle health and causes subsequent muscle wasting. This study
explores the role ofmitochondrial dysfunction as an intramuscular signal for the extracellularmatrix (ECM)–based
proteolysis and, consequentially, muscle cell dystrophy. We found that inhibition of the mitochondrial electron
transport chain causes paralysis as well as muscle structural damage in the nematode Caenorhabditis elegans. This
was associated with a significant decline in collagen content. Both paralysis and muscle damage could be rescued
with collagen IV overexpression, matrix metalloproteinase (MMP), and Furin inhibitors in Antimycin A–treated
animal as well as in the C. elegans Duchenne muscular dystrophy model. Additionally, muscle cytosolic calcium
increased in the AntimycinA–treated worms, and its down-regulation rescued themuscle damage, suggesting that
calcium overload acts as one of the early triggers and activates Furin and MMPs for collagen degradation. In
conclusion, we have established ECM degradation as an important pathway of muscle damage.—Sudevan, S.,
Takiura, M., Kubota, Y., Higashitani, N., Cooke, M., Ellwood, R. A., Etheridge, T., Szewczyk, N. J., Higashitani, A.
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Mitochondrial dysfunction is a frequent characteristic of
several diseases that affect the muscle cell, including
muscle wasting, muscular dystrophy, aging, and disuse
(1–3). Irrespective of mitochondrial dysfunction, there are
several well-known pathways for myofibril protein deg-
radation: lysosome-mediated degradation, autophagy,
caspase-mediated degradation, and calpain-mediated
degradation (4, 5). Although these muscle-regulatory
degradation systems are activated and performed in-
tracellularly, recent studies have reported the impor-
tance of the extracellular matrix (ECM) in maintaining
muscle cell activity and function (6, 7). The ECM is the
physical support and biochemical environment that sur-
rounds a cell and is composed of several components, in-
cluding collagen,which is themost abundant ECMprotein
(8).CollagenVIconnects skeletalmusclewith thebasement
membrane, and hence is important in relaying bilateral
biochemicalmessages from inside cells to theECMandvice
versa (9). From previous studies, it is clear that mitochon-
drial dysfunction is related to muscle atrophy (10), and
ECM stability is necessary for maintaining muscle health;
however, any putative molecular mechanisms linking the
mitochondria, ECM, and muscle are unclear.
The present study addresses the gap in information
about the pathway from mitochondrial dysfunction to
muscle atrophy using Caenorhabditis elegans, an experi-
mental model organism. C. elegans is a powerful tool to
study muscle decline and health because there are exactly
95 body wall muscle cells, and the fate of each muscle cell
from its birth to death can be determined easily. In addi-
tion, in our ownheat strokemodel systemofC. elegans, we
foundthat calciumup-regulation leads todisorderof body
wall muscle cells (11). Through the present study, we re-
port for the first time that mitochondrial dysfunction acts
as an intramuscular signal that, via excessive calcium
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release, activates ECM-degrading enzymes to reduce
ECM content and, subsequently, target muscle structural
and functional decline.
MATERIALS AND METHODS
C. elegans strains and culturing techniques
All strains were cultured on Nematode growth medium (NGM)
plates with OP50 as a food source at 20°C unless otherwise
specified. In the case of temperature-sensitive (TS) mutants, the
worms were grown at a permissive temperature (15°C) and
transferred to a restrictive temperature (25°C) for the experiment
at the specified timeperiod.Standardprotocolswere followed for
the maintenance of all C. elegans strains (12). For RNA in-
terference (RNAi) experiments, adult wormswere transferred to
plates containing isopropyl b-D-1-thiogalactopyranoside and
bacteria expressing double-stranded RNA for unc-68 or emb-9.
The nematode strains used in this study were Bristol strain N2
(WT, wild type), GG34 [emb-9(g34) III], HBR4 {goeIs3 [myo-3p::
GCamP3.35::unc54 39utr + unc-119(+)]}, NF3620 {unc-119(ed3) III;
tkTi1 [emb-9p::emb-9::mCherry+Cb-unc-119(+)]} I], TR2171 [unc-
68(r1162) V], VC48 [kpc-1(gk8) I], and LS587 [dys-1(cx18) I; hlh-
1(cc561) II].
Reagents
AntimycinA (ALX-380-075; EnzoLife Sciences, Farmingdale,NY,
USA) dissolved in 100% ethanol was used for inhibition of mito-
chondrial function. Furin inhibitor I (150113-99-8; Cayman
Chemicals, Ann Arbor, MI, USA) and actinonin (13434-13-4;
Cayman Chemicals) were dissolved in 100% DMSO and used to
inhibit Furin and matrix metalloproteinases (MMPs) at the final
concentrationof 1and10mM,respectively.Rhodaminephalloidin
(219920-04-4) was dissolved in 100% methanol and was used for
staining and visualizing muscle fibers. Rotenone (R8875; Milli-
poreSigma, Burlington,MA,USA) dissolved in 100%DMSOwas
used for inhibition of complex I of the electron transport chain.
Muscle paralysis assay and morphology
Adult animals of N2 or other strains of C. elegans (n = 20 worms
per condition) were treated with different concentrations (0, 2, 4,
and 10 mM) of Antimycin A. After 36 h of treatment at 20°C, the
animals were gently touched using a platinum wire pick to de-
termine whether they were motile for the paralysis assay. For
visualizing the muscle, after treatment with the drugs, the ani-
mals (n = 20) were washed thrice with M9, fixed using 1%
paraformaldehyde for 10min, and stored at 4°C. Theywere then
washed twice with M9 and permeabilized using 100% acetone
for 1 min. This was followed by 2morewashes withM9 and the
addition of rhodamine phalloidin (12 U/ml). The worms were
incubated in thedye indark conditions for 2 h and thenmounted
onglass slides. Confocalmicroscopy (FluoViewOlympus FV10i;
Olympus, Tokyo, Japan) was used to visualize and image
the myofibrils. In the case of Furin (1 mM) or MMP (10 mM)
inhibition, the inhibitors were added at the same time as
Antimycin A.
Protein extraction and Western blot analysis
Following treatment with Antimycin A, animals expressing
EMB-9::mCherry (n = 300) were collected in 1.5-ml microfuge
tubes. After 2washeswithM9 buffer, animalswere immediately
frozen in liquid N2. This was followed by thawing and addition
of 100 ml of 1-time SDS dye. Next, the tubes were placed in a
liquidbath sonicator (Bioruptor;CosmoBio, Tokyo, Japan)on5-s
on and off cycles for 10 min, followed by incubation at 95°C for
10min.Sampleswere thenrunonan8%SDSgel, afterwhich they
were transferred onto a PVDFmembrane (88518; Thermo Fisher
Scientific,Waltham,MA,USA) andblocked in 5%skimmedmilk
for 1 h. Next, the membrane was incubated overnight at 4°C in
primary antibody (anti-mCherry, ab125096, anti-a-tubulin,
ab7750; Abcam, Cambridge, MA, USA) prepared in 2.5% milk.
This was followed by 1washwith 1-time PBSwith Tween 20 for
5min, and themembranewas transferred to secondary antibody
(sheep anti-mouse; GE Healthcare, Waukesha, WI, USA;
NA93IV, po448, goat anti-rabbit, Agilent Technologies, Santa
Clara, CA, USA) incubated at room temperature for 3 h. The
membrane was washed thrice with 1-time PBS with Tween 20,
and thebandswere thenvisualizedusinga chemifluorescencekit
(Western Lightning Plus-ECL; Takara, Kyoto, Japan).
Calcium assay method
HBR4 {goeIs3 [myo-3p::GCamP3.35::unc54 39utr + unc-119(+)]}
was used to assay calcium concentration in the body wall mus-
cles ofC. elegans after 36 h treatmentwithAntimycinA.Analysis
wasdoneusing aBX51 fluorescentmicroscope (Olympus)with a
DC73 charge-coupled device camera (Olympus) and an FV10i
confocal laser scanning microscope (Olympus). Green fluores-
cent protein intensity was measured using ImageJ (National In-
stitutes of Health, Bethesda, MD, USA) software.
ATP assay
Adult synchronized animals of wild-type (WT) C. elegans were
treated with different concentrations (0, 2, 4, and 10 mM) of
AntimycinAfor24h,afterwhich theendogenousATPlevelswere
measured by using anATPDeterminationKit (Molecular Probes,
Eugene, OR, USA) as previously described byMomma et al. (11).
Mass spectrometry
The synchronized adult animals (;700 worms each treatedwith
0, 4, and 10 mM Antimycin A for 24 h) were washed with M9
buffer, and their total protein was extracted with 8.4 M urea
solutionandsonication (UR-20P;TomySeiko,Tokyo, Japan). The
crude extracts were denatured, reduced, and digested with
trypsin overnight at 37°C (13). The digested peptides were la-
beled with Applied Biosystems iTraq Reagents according to the
manufacturer’s instructions (Thermo Fisher Scientific). Each
peptide was quantitatively analyzed using an LTQ Orbitrap
Velos with an electron-transfer dissociation mass spectrometer
(Thermo Fisher Scientific) equipped with a PAL HTC‐xt auto-
sampler (PALSystem;AmericanMedical Response, Greenwood
Village, CO,USA) and a nano-AdvanceUHPLC system (Bruker,
Billerica, MA,USA) as previously described by Pancha et al. (14).
Oxygen-consumption rate assay
All control and Antimycin A– or rotenone-treated animals were
prepared as described above for analysis of 36-h postadulthood
animals. Seahorse XFe24 flux assay kits (Agilent Technologies)
were hydrated using 1 ml of Seahorse XF calibration solution in
each well and incubated overnight at 37°C in a humidified non-
CO2 incubator. The Seahorse 24-well plate reader was also
allowed to equilibrate overnight with the temperature set to
18°C. Plate template was set up using assay wizard to provide a
random distribution of conditions across the plate. When
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preparing the animals, samples were washed (3 times, 3 3 10
min) to rinse excess bacteria and clear the gut of E. coli. Ap-
proximately 20 animals were counted per well (and precise
worm count recorded) with 5 replicates per condition and awell
volume of 525 ml M9 buffer. Basal respiration measurements
were taken for 4 cycles for calculation of oxygen-consumption
rate (OCR). Each measurement cycle consisted of a 2-min mix
step, a 3-min wait step, and a 3-min measuring period. All con-
ditions were analyzed over 2 Seahorse experiments for a total of
10 replicates of 20 worms per condition. Absolute OCR mea-
surements were normalized per worm.
Statistical analysis
RStudio software (https://www.rstudio.com/) was used to de-
termine statistical significance. Statistical analysis was per-
formed using 1-way ANOVA followed by Tukey’s post hoc
test. The minimum P value for significance was 0.05. Similar
letters in any 2 groups indicate no significance, and different
letters in any 2 groups represent significant difference be-
tween the 2 groups.
RESULTS
Mitochondrial dysfunction mediated by
Antimycin A results in muscle damage
in C. elegans
Treatment with a mitochondrial electron transport chain
inhibitor Antimycin A resulted in worm paralysis as well
asmuscle damage inWTworms (Fig. 1A, B). Almost 50%
of adult worms were paralyzed after treatment with
10 mM Antimycin A, whereas 2 and 4 mM treatment ex-
hibit;7and20%paralysis, indicatingmuscular functional
decline as a direct consequence of mitochondrial dys-
function. Analysis of muscle structure using rhodamine
phalloidin further reveals abnormal muscle structure,
which resembles the dystrophy observed in dys-1; hlh-1
mutant animals (15). Varying degrees of muscle damage
were observed in these worms. The most common ab-
normal structural phenotype observed in these cases is
that of wavy actin filaments compared with the straight
parallel alignment observed in healthy muscle cells. In
some cases, however, we also observe severely damaged
muscle cells with broken myofilaments (Fig. 1C). The
number of Antimycin A–damagedmuscles also increased
in a dose-dependent manner; ;43 and 50% muscles are
dystrophic after 2 and 4 mM Antimycin A treatment,
which increases to ;70% following 10 mM treatment.
Notably, although we found a significant percentage of
muscle damage following exposure to 2mMAntimycinA,
wedidnotobserveparalysis in this condition, suggestinga
certain degree of mitochondrial dysfunction–induced
muscle damage can be tolerated without translating to a
functional decline. At first glance, it can be predicted that
paralysis is caused as a result of depletion ofATP,which is
an established feature of Antimycin A treatment. Endog-
enous ATP levels after Antimycin A treatment distinctly
reducedbymore thanhalf but didnot change significantly
between 2, 4, and 10 mM Antimycin A treatment com-
pared with controls (Supplemental Fig. S1). Hence, ATP
alone cannot explain the effect of Antimycin A treatment
on the worm’s muscle cells.
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Figure 1. Mitochondrial dysfunction mediated
by Antimycin A results in paralysis and muscle
cell damage in C. elegans. Age-synchronized WT
animals were grown to young adulthood at
20°C. A) Adult animals were then treated with
0 (C, control), 2, 4, and 10 mM Antimycin A for
36 h, after which the animals were analyzed
with a platinum wire pick for movement
defects/paralysis. Values indicate the percent-
age of animals paralyzed in each group. Twenty
animals were analyzed for each experiment
with 3 independent repetitions (n = 60 ani-
mals). A significant increase in paralysis was
observed in 10 mM concentration. B) Muscle
structure was visualized using rhodamine phal-
loidin after 36 h treatment with Antimycin A.
Values indicate the average percentage of
damaged muscle per animal. A significant
increase in damaged muscle cells was observed
in 2, 4, and 10 mM Antimycin A. Number of
muscle cells per condition (n = 63, 54, 74, and
85 from left to right). C) Representative images
of myofilament alignment in normal and
Antimycin A–damaged muscle cells. The dam-
aged muscle displays wavy myofilaments and
large gaps in between compared with normal
muscle cells. Cont., control. Scale bars, 10 mM.
Letters (a, b) on top of bars indicate statistical
significance; X, median value.
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Figure 2. emb-9 is degraded upon mitochondrial dysfunction caused by Antimycin A. A) Synchronized adult worms expressing
emb-9::mCherry were treated with 0 (C, control), 2, 4, and 10 mM Antimycin A. After 36-h treatment with Antimycin A, animals
were subjected to lysis, and Western blot was performed to analyze the amount of EMB-9 protein using anti-mCherry antibody. B)
ImageJ was used to quantify the amount of EMB-9 protein, which was normalized to total tubulin content. Graph was prepared
based on the values of the normalized amount of EMB-9; a significant decrease in EMB-9 was observed in 10 mM Antimycin A (3
biologic repeats). C) emb-9 TS mutant animals were synchronized and grown to young adulthood at 15°C (permissive
temperature), after which the adult worms were either grown at 15°C or shifted to 25°C for up to 3 d. At D1, D2 and D3, animals
were monitored for muscle damage using rhodamine phalloidin staining and confocal microscopy. A significant increase in
muscle damage was observed in animals grown at the restrictive temperature at D1, D2, and D3 when compared with their
(continued on next page)
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Mitochondrial dysfunction causes muscular
ECM collagen degradation
The ECM is crucial for not only maintaining the physical
structure of a cell but also to provide it with an external
biochemical environment that helps to mediate cellular
activities via bilateral transmission of chemical cues. The
predominant muscle dystrophy phenotype we observed
was wavy actin filaments. Because of the wavy myofila-
ment phenotype and previous reports highlighting the
significance ofmuscle ECM (6), we consideredwhether a
change in muscle attachment with the ECM or the com-
position of the ECM itself might be responsible for loss of
myofilament anchoring and, therefore, wavy sarcomere
structure. Collagen is themajor ECMcomponent, andwe
first analyzed changes in muscular collagen IV-a-1
(EMB-9 in C. elegans) after Antimycin A treatment using
the NF3620 strain (emb-9::mCherry) (16). A progressive
decrease in EMB-9::mCherry fusion protein was ob-
served with increasing concentration of Antimycin A
(Fig. 2A), with 30 and 40%decreases in EMB-9 after 2 and
4 mM treatment. Significant decrease in EMB-9 was ob-
served in the 10 mM Antimycin A condition with a deg-
radationof;60%ofEMB-9::mCherry fusionprotein (Fig.
2B).We also observed a;30%decline inmuscular LET-2
(collagen IV-a-2) protein after treatment with 4 and
10mMAntimycinA throughmass spectrometric analysis
(Supplemental Table S1). To gain further evidence for the
role of EMB-9 inmusclemaintenance,wemonitored emb-
9mutant animals. Because EMB-9 is an essential protein,
the absence of which leads to embryonic lethality, we
employed TS emb-9 mutants, which grow well at the
permissive temperature (15°C) but fail to produce prog-
eny at the restrictive temperature (25°C). We analyzed
themuscle structure of adult emb-9mutants after 1, 2, and
3 d of incubation at the restrictive temperature and
observed wavy actin filaments, which increase in a
time-dependent manner (the percentage of dystrophic
muscles increases from 25% on d 1 to 35% on d 3, Fig.
2C). However, it was also observed that the muscle
damage seen in case of Antimycin A treatment, even at
the 2 mM condition, was more severe than the one ob-
served in the case of the emb-9 mutant (Fig. 2C). This
could be because more than 1 ECM protein is re-
sponsible for themuscle damage in case of AntimycinA
treatment (e.g., LET-2). It can be noted that muscle
damage also increases at the permissive temperature
in a time-dependentmanner,whichmight be because of
a leaky expression of the mutant protein. Furthermore,
emb-9 RNAi shows myofilament abnormalities in
the muscle cells of MYO3::green fluorescent protein
expressing C. elegans (Supplemental Fig. S2).
To determine whether EMB-9 positively regulates
muscle structure and prevents muscle damage in the
context of mitochondrial dysfunction, we examined the
effect of EMB-9 overexpression in Antimycin A–treated
NF3620 worms. We found that EMB-9 overexpression
animals exhibit complete resistance to paralysis in all 3
concentrations of Antimycin A and, especially, there is
significant rescue of paralysis in the 10 mM Antimycin A
conditionwhen comparedwithWT animals (Fig. 2D).We
also found a decrease inmuscle damage in the 2 and 4mM
Antimycin A treatment conditions, but a significant de-
crease was observed in the 10 mMAntimycin A condition
compared with WT treatment conditions (Fig. 2E). These
results clearly show the importance of muscular ECM
collagens in maintaining and protecting muscle structure.
Thus, our findings provide the first evidence that mito-
chondrial dysfunction serves as an intramuscular signal
for ECM degradation and subsequent muscle damage.
MMP activation mediates the
ECM degradation
MMPs are a set of proteases involved in thedegradation of
collagen and other ECM proteins. Furin is a proprotein
convertase that is required for the activation of MMPs.
Both Furin and MMPs require calcium for their activity
(17–19). Because we noticed a decrease in EMB-9 and
LET-2 protein after Antimycin A treatment, we next
monitored the effect of MMP inhibition on Antimycin
A–treated WT C. elegans. We found that MMP inhibition
completely rescuedworm paralysis in all 3 concentrations
ofAntimycinA(Fig. 3A).Also, therewas significant rescue
of muscle damage in all 3 conditions when treated along
with MMP inhibitor. The muscle damage dropped from
;43, 50, and 70% in 2, 4, and 10 mMAntimycin A–treated
animals to ;10, 15, and 32% in animals treated with an
MMP inhibitor along with Antimycin A (Fig. 3B). Addi-
tionally, both Furin mutant kpc-1 and Furin inhibitor
completely rescued paralysis caused by Antimycin A
treatment (Fig. 3A). They also significantly rescued the
number of damaged muscle cells from ;43 and 50% to
,15% in both 2 and 4 mMAntimycin A treatment condi-
tions. It was interesting to observe that, even at the 10 mM
Antimycin A condition, the muscle damage drastically
reduced from70 to28%in thecaseofFurinmutantanimals
and 70 to 20%with the application of Furin inhibitor along
with Antimycin A treatment (Fig. 3B). In addition to
type-IV collagen (EMB-9 and LET-2), 2 cuticle collagens
(COL-19 and COL-119) are also reduced by Antimycin A
treatment (Supplemental Table S1). These are orthologs of
human surfactant protein D, which is cleaved by MMP-9
respective permissive temperature conditions. The pattern of this muscle damage is illustrated in the representative images.
Number of muscle cells per condition (n = 260, 196, 270, 312, 177, and 347 from left to right). Scale bars, 10 mM. D, E) Antimycin
A–treated emb-9 OP worms were scored for worm paralysis and muscle damage as performed in Fig. 1A, B. Significant rescue of
the paralysis phenotype was observed following 4 and 10 mM Antimycin A treatment, and muscle damage was recovered after
10 mM Antimycin A treatment. Twenty animals were analyzed for each experiment with 3 independent repetitions (n = 60
animals). Number of muscle cells per condition (n = 113, 106, 78, and 96 from left to right). The data for WT are the same as
those used in Fig. 1A, B. They have been repeated here and in the following figures for comparison. OP, overexpression; pt,
permissive temperature; rt, restrictive temperature. Letters (a–d) on top of bars indicate statistical significance; X, median value.
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in vitro (20). These results clearly indicate that mitochon-
drial dysfunction activates Furin and MMPs, which cata-
lyze ECM collagen degradation. To confirm this, we
analyzedwhetherMMP and Furin inhibitors could rescue
EMB-9degradation causedbyAntimycinA treatment.We
found no significant change in EMB-9 content with in-
creasing concentrations of Antimycin A when treated
along with MMP and Furin inhibitors (Fig. 3C and Sup-
plemental Fig. S3A, B).
Calcium signaling is up-regulated by
mitochondrial dysfunction through the
sarcoplasmic reticulum ryanodine receptor
and the plasma membrane EGL-19 channel
In one of our previous publications,we could see that heat
stress leads to cytoplasmic calcium overload and mito-
chondrial fragmentation, possibly through endoplasmic
reticulum (ER) stress. It has also been reported that Re-
active Oxygen Species (ROS) can also lead to calcium
overload, andAntimycinAtreatment is knowntoenhance
both mitochondrial ROS as well as cytoplasmic ROS (21).
Because calcium is required for the activationof bothFurin
and certain MMPs, we proceeded to examine the role of
calcium in Antimycin A–mediated muscle damage. For
this, we employed a muscular GCaMP calcium sensor, a
genetically encoded calcium indicator (11, 22). We found
rise in muscle cytoplasmic calcium levels with increasing
concentrationsofAntimycinAtreatment,whichcorrelates
well with the progressive increase in muscle damage ob-
served before. As the calcium current is essential for
muscle contraction, a calcium rise can be seen in the con-
tracted side (orange arrowhead) of the body in WT con-
trols. However, in Antimycin A–treated animals, the
calcium rise is visible throughout the body wall muscle
regardless ofmuscle contraction, both on the contracted as
well as the relaxed side (white arrowhead) (Fig. 4A).When
Figure 3. Inhibition of MMPs and Furin rescues
the muscle paralysis, muscle damage, and
collagen degradation mediated by Antimycin
A. Adult synchronized animals (WT, kpc-1) were
treated with 0 (C, control), 2, 4, and 10 mM
Antimycin A along with 10 mM MMP inhibitor
or 1 mM Furin inhibitor for 36 h, after which
they were scored for worm paralysis and muscle
damage. A) Significant rescue was observed in
paralysis (2, 4, and 10 mM) in the presence of
MMP inhibition or Furin inhibition. Twenty
animals were analyzed for each experiment with
3 independent repetitions (n = 60 animals). B)
Significant rescue was observed in muscle
damage in 2, 4, and 10 mM Antimycin A
treatment condition with MMP inhibitor, Furin
inhibitor, and kpc-1 mutant worms. Number of
muscle cells per condition (n = 98, 116, 130, 102,
105, 126, 118, 165, 210, 342, 306, and 203 from
left to right for MMP inhibitor, Furin inhibitor,
and kpc-1). C) Synchronized adult worms
expressing emb-9::mCherry were treated with
0, 2, 4, and 10 mM Antimycin A along with 10
mM MMP inhibitor or 1 mM Furin inhibitor.
After 36-h treatment with Antimycin A, animals
were subjected to lysis, and Western blot was
performed to analyze the amount of EMB-9
protein using anti-mCherry antibody. No signif-
icant change in EMB-9 was observed with the
application of MMP and Furin inhibitors (3
biologic repeats). Inh., inhibitor. Letters (a–d)
on top of bars indicate statistical significance; X,
median value.
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we calculated the ratio of the relative intensity of calcium
on the relaxed side to the contracted side, we found a
significant increase in 4 and 10 mMAntimycin A (Fig. 4B).
Subsequently, we had to determine the mechanisms reg-
ulating this calcium overload caused by mitochondrial
dysfunction. The ryanodine receptor (RyR) UNC-68 is
one of the major intracellular calcium channels on the
sarcoplasmic reticulum (SR) for calcium release (23), and
EGL-19, a voltage-gated calcium channel, localizes on
the muscle plasma membrane for entry of calcium from
outside the cell (24). Null mutants of egl-19 are lethal,
whereas a reduction of function causes feeble contraction
of body wall muscle cells, possibly because of reduced
calcium entry (24, 25). RyRs, including UNC-68, also are
Figure 4. Inhibition of calcium overload could rescue muscle damage and EMB-9 degradation in Antimycin A–treated C. elegans.
A, B) Animals expressing the calcium sensor GCaMP3.35 were age synchronized at the L1 stage and grown to young adulthood at
20°C. Adults were treated with 0 (C, control), 2, 4, and 10 mM Antimycin A for 36 h, after which they were imaged using
fluorescence microscopy with objective lens, 310 magnification (UPlanAPO, Olympus) (A) and the calcium level quantified (B)
using ImageJ software. A significant rise in intracellular calcium was observed following treatment with 4 and 10 mM Antimycin A.
Five animals were analyzed for each condition. C) Synchronized adult animals [WT, unc-68(r1162) V and egl-19(ad695) IV] were
treated with 0 (C, control), 2, 4, and 10 mM Antimycin A for 36 h and scored for muscle damage as performed in Fig. 1B. When
compared with WT animals, there was significant rescue or decrease in muscle damage in both mutants at 2, 4, and 10 mM
Antimycin A. Number of muscle images per conditions (167, 218, 301, 273, 64, 80, 74, and 42 from left to right). D) Synchronized
adult worms expressing emb-9::mCherry were treated with 0 (C, control), 2, 4, and 10 mM Antimycin A along with unc-68 double-
stranded RNA–containing bacteria. After 36-h treatment with Antimycin A, animals were subjected to lysis, and Western blot was
performed to analyze the amount of EMB-9 protein using anti-mCherry antibody. No significant decrease in EMB-9 was observed
with unc-68 RNAi after Antimycin A treatment (3 biologic repeats). Letters (a–d) on top of bars indicate statistical significance; X,
median value.
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responsible for excitation-contraction coupling through
calciuminducedcalciumrelease fromtheSR(26).Mutation
in unc-68 as well as egl-19 significantly rescued the muscle
damage in all 3 concentrations of Antimycin A, decreasing
it from 43–10% and 7% in 2mM, 49–12% and 17% in 4mM,
and 70–25% and 18% in 10mMAntimycinA in unc-68 and
egl-19 mutants, respectively (Fig. 4C). Thus, the reduction
of calcium entry into the cell through EGL-19 as well as
reduced release of calcium from the SR into cytoplasm
through UNC-68 could rescue the Antimycin A–induced
muscle damage.Moreover, unc-68RNAi could also rescue
EMB-9 degradation significantly, suggesting that calcium
overload through these channels is responsible for the ac-
tivationofFurinandMMPs (Fig. 4DandSupplementalFig.
S3C). The increase in calcium could be the direct result of
ROS generated as a by-product of mitochondrial dys-
function because it has been shown that ROS-mediated
oxidation of RyR (UNC-68) can increase its activity,
resulting in cytosolic calcium overload (21).
Rotenone-mediated muscle damage has a
different mechanism than Antimycin A
Because we could successfully show that mitochondrial
dysfunction mediated by Antimycin A causes muscle
damage through ECMdegradation, wewere interested to
see whether similar effects would appear with other mi-
tochondrial inhibitors. We used rotenone in the same
concentrations as Antimycin A because the OCR was re-
duced in a similar manner between both treatments
(Supplemental Fig. S5A, B). Intriguingly, rotenone did not
affect themuscle cells in away similar toAntimycinA.We
found no muscle damage with 2 and 4 mM rotenone
treatment, but significant muscle damage was seen in the
10 mM condition (Fig. 5A and Supplemental Fig. S4). Be-
cause calcium overload is one of the earliest responses for
the muscle damage in the Antimycin A model, we exam-
ined thecalciumconcentration in rotenone-treatedworms.
Surprisingly,we foundnosignificant rise in calcium inall 3
concentrations of rotenone (Fig. 5B). We also examined
whether the muscle damage observed in the 10 mM rote-
none condition could be rescued with Furin or MMP in-
hibition. We found that both the inhibitors fail to rescue
muscle damage observed in 10 mM rotenone–treated
worms (Fig. 5A). Because calcium overload is essential for
Furin andMMPactivation, this result was expected. It can
be concluded that cytoplasmic calcium overload is re-
sponsible for muscle damage in Antimycin A–treated
worms, especially because rotenone treatment generates
mitochondrial ROS, which is restricted inside the mito-
chondrial matrix and hence cannot oxidize RyR and cause
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Figure 5. Rotenone treatment causes muscle
damage but not calcium overload in C. elegans.
A) Adult synchronized animals were treated with
0 (C, control), 2, 4 and 10 mM Rotenone for 36 h
with or without MMP inhibitor (10 mM) or Furin
inhibitor (1 mM), after which they were scored
for muscle damage. Significant muscle damage
was found in 10 mM rotenone, which could not
be rescued with MMP or Furin inhibitor.
Number of muscle images per conditions (269,
231, 144, 197, 280, 228, 207, 112, 257, 155, 217,
and 169 from left to right). B) Adults expressing
GCaMP3.35 were treated with 0 (C, control), 2, 4
and 10 mM Rotenone for 36 h, after which they
were imaged using fluorescence microscopy with
objective lens, 310 magnification, and the
calcium level quantified using ImageJ software.
No significant change in calcium was observed in
all 3 concentrations. Five animals were analyzed
for each condition. Inh., inhibitor. Letters (a, b)
on top of bars indicate statistical significance; X,
median value.
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cytoplasmic calcium overload (27). Thus, in the case of
rotenone treatment, alternative pathways might be re-
sponsible for muscle damage at very high (10 mM) doses.
Duchenne muscular dystrophy muscle decline
is rescued by Furin and MMP inhibition
Duchenne muscular dystrophy (DMD) is a genetic disor-
der caused by a mutation in the dystrophin gene. Dys-
trophin is responsible for the maintenance of plasma
membrane stability, and its absence leads to muscular
dystrophy. Previous literature has reported calcium dys-
regulation and mitochondrial dysfunction in DMD, (28,
29) and, more recently, reduced mitochondrial function
andcalciumoverloadhasbeendemonstrated inaC. elegans
model of DMD (30, 31). Because the dystrophin gene is
conserved inC. elegans, thewell-establishedDMDmodel
ofC. elegans (dys-1; hlh-1mutant) is a goodmodel system
to further explore the role of mitochondrial dysfunction
or ECM degradation in muscle maintenance (15). To
validate our findings regarding the importance of col-
lagen in protecting muscle cells against dystrophy, we
examined whether Furin and MMP inhibition could
suppressmuscledamage in theDMD-modelworms. The
mutant accumulates a high degree of muscle damage
(15), and we found 93% of muscle cells with damaged
myofilaments that, although higher than that seen with
Antimycin A treatment, displayed a similar pattern of
wavy and brokenmyofilament (Fig. 6A, B). Intriguingly,
treatment with Furin or an MMP inhibitor resulted in a
significant reduction in muscle damage, from 93 to 27%
upon Furin inhibition and 55% with MMP inhibition
(Fig. 6A, B). Likewise, unc-68 inhibition through RNAi
significantly rescued muscle damage in dys-1; hlh-1
mutants from 93 to 55% (Fig. 6A). This leads us to con-
clude that calcium overload is the first of multiple steps
by which chemical- (Antimycin A) and disease (DMD)-
related mitochondrial dysfunction causes muscle dam-
age through ECM degradation.
DISCUSSION
In this study,we have shownECMdegradation as a novel
pathway of muscle degeneration whereby reduced or al-
tered collagen can result in muscle damage. The results
corroborate previous studies conducted in collagen-null
mice and cell lines that have provided important insight
into the function of ECM with respect to mitochondrial
function and muscle cell apoptosis as well as defective
autophagymechanism (7, 32). Importantly, we found that
maintaining collagen content in the face of mitochondrial
dysfunction through MMP and Furin inhibition could
delay muscle damage for a significant period of time.
Calcium overloadwas found to be one of the first steps in
the sequential activation of ECM degradation, leading to
muscle disorganization. Using forward genetics and mu-
tant strains, we found that 2 important calcium receptors,
egl-19 and unc-68, are responsible for the calciumoverload
in C. elegans muscle. Mutation in either of these calcium
receptors (egl-19 and unc-68) prevents excess cytosolic cal-
cium accumulation, which results in rescue of the muscle
damage phenotype. These results highlight cytosolic cal-
cium influx as a key intermediary step in the muscle
damage caused by mitochondrial dysfunction. Moreover,
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Figure 6. DMD muscle phenotype can be rescued with Furin inhibition. A) dys-1; hlh-1 mutant animals were synchronized from
the L1 stage and grown to young adulthood at 15°C (permissive temperature). Adult animals were then transferred to fresh NGM
plates containing 1 mM Furin inhibitor or 10 mM MMP inhibitor or unc-68 RNAi plates and grown at 25°C (restrictive
temperature) for 48 h. There was a significant decrease in the occurrence of muscle damage in dys-1; hlh-1 animals when treated
with 1 mM Furin inhibitor, 10 mM MMP inhibitor, and unc-68 RNAi. B) Representative image of a muscle cell of dys-1; hlh-1
animals in the absence and presence of a Furin inhibitor. Number of muscle cell images per condition (n = 152, 109, 217, and 99
from left to right). Here, control animals are DMD animals treated with DMSO. Cont., control; inh., inhibitor. Scale bars, 10 mM.
Letters (a–c) on top of bars indicate statistical significance; X, median value.
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rotenone-mediated muscle damage could not be rescued
significantly with the application of Furin and MMP in-
hibitors because of the absence of calcium overload, which
acts as a crucial step for Furin and MMP activation. This
could be because rotenone treatment generates ROS that is
restricted to mitochondrial matrix and hence cannot acti-
vate calcium overload by oxidation of RyR (21, 27).
Calcium dysregulation is also one of the preliminary
steps in DMD. Previous studies have elucidated the
mechanism of disease manifestation in DMD through
plasma membrane instability and excessive calcium in-
flux. It is unclear how this calcium overload results in
muscle degeneration in DMD. We found that we could
significantly delay muscle degeneration in the C. elegans
model of DMD through unc-68, MMP, and Furin in-
hibition.Our results indicate that ECMdegradation canbe
one of the pathways that is activated in response to cal-
cium overload, resulting in muscle degeneration in DMD
as well as muscle damage mediated by Antimycin A.
In summary, we propose a novel bilateral mechanism
of muscle maintenance whereby mitochondrial dysfunc-
tion serves as an intramuscular cue for deregulated cyto-
solic calcium release, possibly through oxidation of
UNC-68. This calcium overload subsequently activates
the calcium-sensitive Furin-MMP-ECM degradation axis,
which destabilizes sarcomeric myofilament anchoring to
the ECMand ultimately leads tomuscle structural decline
and paralysis (Fig. 7). In addition, it can be speculated that
ECMdegradation also affects plasmamembrane stability,
causing further ionic influx. This would create a negative
feedback loop ultimately resulting in muscle cell death
through apoptosis. Dandrolene, a unc-68 inhibitor, was
found to be effective against DMD in the mouse model
of DMD (33). Because MMP and Furin inhibition could
attenuate mitochondrial dysfunction–mediated mus-
cle damage, we propose MMP and Furin inhibitors as
promising candidates for drugs against muscle-wasting
conditions characterized by mitochondrial dysfunction,
including DMD but also aging and disuse or bedrest.
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